There are no effective treatments for retinitis pigmentosa – jCyte is working to change that.
Our approach is simple: inject retinal progenitor cells directly into the eye, where they can protect photoreceptors and preserve sight. This revolutionary cell-based therapy is easy to administer and requires no surgery or permanent devices.
Retinitis Pigmentosa Explained
jCyte is working on the world’s first therapy for retinitis pigmentosa. Learn about RP and how transplanted retinal progenitor could stop the disease.